Brief: Ultimovacs Q3 Operating Loss Widens To NOK 31.1 Million
12/11/2020 07:08
Nov 12 (Reuters) - Ultimovacs ASA ULTIMO.OL :
* Q3 OPERATING LOSS NOK 31.1 MILLION VERSUS LOSS NOK 19.3
MILLION
YEAR AGO
Source text for Eikon: ID:nObi0W554a
Further company coverage: ULTIMO.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785110;))
Recent news on Zelluna ASA
See all newsNorway's Zelluna ASA reports Q2 loss
Brief: Zelluna Reports Q2 Total Loss Of NOK 19.7 Million
Brief: Zelluna Says IDMC Recommends Recruitment Of Next Two Patients At First Dose Level
Brief: Zelluna Says First Patient Dosed With Zi-Ma4-1 In Zima-101 Phase 1 Trial
Brief: Zelluna Wins NOK 16 Mln Research Council Of Norway Grant